60 Degrees Pharmaceuticals, Inc. (SXTP) Insider Ownership

Through the 90-day period concluding February 19, 2026, 60 Degrees Pharmaceuticals's top three insider stakeholders include President And Ceo Geoffrey S Dow (14.90K shares), Director Cheryl Xu (3.95K shares), Cfo Tyrone Miller (330 shares).

• The shareholding composition of 60 Degrees Pharmaceuticals (SXTP) reflects broad market participation, with institutional funds owning 4.79%, executive insider stakes representing 2.07%, with public and others accounting for 93.13%.
• As of February 19, 2026, insider ownership at 60 Degrees Pharmaceuticals represents 2.07% of the company's total outstanding shares, comprising approximately 19.19K shares out of 925.45K outstanding shares.
• 60 Degrees Pharmaceuticals's insider ownership increased by 51.97% during the 90-day period ending February 19, 2026, with total insider holdings growing from 12.63K shares to 19.19K shares.
• Over the past 90 days through February 19, 2026, President And Ceo Geoffrey S Dow demonstrated the strongest insider purchase conviction at 60 Degrees Pharmaceuticals, adding 22.63K shares to their position.
• 60 Degrees Pharmaceuticals had no significant insider sales in the last 90 days.